Maguire TM - Search Results

1

High levels of cathepsin B predict poor outcome in patients with breast cancer.

Maguire TM, Shering SG, Duggan CM, McDermott EW, O'Higgins NJ, Duffy MJ. Maguire TM, et al. Int J Biol Markers. 1998 Jul-Sep;13(3):139-44. doi: 10.1177/172460089801300303. Int J Biol Markers. 1998. PMID: 10079387

2

Assay of E-cadherin by ELISA in human breast cancers.

Maguire TM, Shering SG, McDermott EW, O'Higgins N, Fennelly JJ, Crown J, Duffy MJ. Maguire TM, et al. Eur J Cancer. 1997 Mar;33(3):404-8. doi: 10.1016/s0959-8049(97)89013-2. Eur J Cancer. 1997. PMID: 9155524

3

Urokinase plasminogen activator: a prognostic marker in multiple types of cancer.

Duffy MJ, Maguire TM, McDermott EW, O'Higgins N. Duffy MJ, et al. Among authors: maguire tm. J Surg Oncol. 1999 Jun;71(2):130-5. doi: 10.1002/(sici)1096-9098(199906)71:2<130::aid-jso14>3.0.co;2-9. J Surg Oncol. 1999. PMID: 10389872 Review.

4

Studies on oestrogen receptor-alpha and -beta mRNA in breast cancer.

Cullen R, Maguire TM, McDermott EW, Hill AD, O'Higgins NJ, Duffy MJ. Cullen R, et al. Among authors: maguire tm. Eur J Cancer. 2001 Jun;37(9):1118-22. doi: 10.1016/s0959-8049(01)00088-0. Eur J Cancer. 2001. PMID: 11378342

5

Overexpression of the Ets-1 transcription factor in human breast cancer.

Buggy Y, Maguire TM, McGreal G, McDermott E, Hill AD, O'Higgins N, Duffy MJ. Buggy Y, et al. Among authors: maguire tm. Br J Cancer. 2004 Oct 4;91(7):1308-15. doi: 10.1038/sj.bjc.6602128. Br J Cancer. 2004. PMID: 15365563 Free PMC article.

6

Ets2 transcription factor in normal and neoplastic human breast tissue.

Buggy Y, Maguire TM, McDermott E, Hill AD, O'Higgins N, Duffy MJ. Buggy Y, et al. Among authors: maguire tm. Eur J Cancer. 2006 Mar;42(4):485-91. doi: 10.1016/j.ejca.2005.10.018. Epub 2005 Dec 27. Eur J Cancer. 2006. PMID: 16380248

7

Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer.

Duggan C, Maguire T, McDermott E, O'Higgins N, Fennelly JJ, Duffy MJ. Duggan C, et al. Int J Cancer. 1995 May 29;61(5):597-600. doi: 10.1002/ijc.2910610502. Int J Cancer. 1995. PMID: 7768629

8

Urokinase plasminogen activator as a predictor of aggressive disease in breast cancer.

Duffy MJ, Duggan C, Maguire T, Mulcahy K, Elvin P, McDermott E, Fennelly JJ, O'Higgins N. Duffy MJ, et al. Enzyme Protein. 1996;49(1-3):85-93. doi: 10.1159/000468618. Enzyme Protein. 1996. PMID: 8796999

9

High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer.

McCarthy K, Maguire T, McGreal G, McDermott E, O'Higgins N, Duffy MJ. McCarthy K, et al. Int J Cancer. 1999 Feb 19;84(1):44-8. doi: 10.1002/(sici)1097-0215(19990219)84:1<44::aid-ijc9>3.0.co;2-p. Int J Cancer. 1999. PMID: 9988231

10

Low levels of urokinase plasminogen activator components in basal cell carcinoma of the skin.

Maguire T, Chin D, Soutar D, Duffy MJ. Maguire T, et al. Int J Cancer. 2000 Feb 15;85(4):457-9. Int J Cancer. 2000. PMID: 10699914

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters